Comparing Decision on Aesthetics After Breast Cancer Locoregional Treatment.

NAActive, not recruitingINTERVENTIONAL
Enrollment

1,030

Participants

Timeline

Start Date

August 8, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

December 31, 2026

Conditions
Breast Cancer
Interventions
DEVICE

Artificial Intelligence and Digital Health Arm

A previous large database repository of images having thousands of pre and postoperative photographs of breast cancer patients proposed for locoregional treatment with clinical and biometric data will be matched using artificial intelligence within the CANKADO platform. Patients proposed for breast cancer locoregional treatment will have access to the software installed, and they will have access to all the information about the type of treatment they will receive. All the questions and questionnaires will be filled out online, and they can visualise the expected outcome from excellent to poor.

Trial Locations (6)

20132

IRCCS Ospedale San Raffaele, Milan

52621

Sheba Medical Center, Ramat Gan

69120

Universitätsklinikum Heidelberg, Heidelberg

80-210

Copernicus Mamma Centrum, Wojewodzkie Centrum Onkologii, Copernicus Podmiot Leczniczy, Gdansk

Gdański Uniwersytet Medyczny, Gdansk

1400-038

Champalimaud Research and Clinical Centre, Champalimaud Foundation, Lisbon

All Listed Sponsors
collaborator

European Commission

OTHER

collaborator

INESC TEC - Institute for Systems and Computer Engineering, Technology and Science (Porto, Portugal)

UNKNOWN

collaborator

Cankado GmbH

INDUSTRY

collaborator

FCiências.ID - Associação para a Investigação e Desenvolvimento de Ciências (Lisbon, Portugal)

UNKNOWN

collaborator

Bocconi University

OTHER

lead

Fundacao Champalimaud

OTHER